Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* 6-10 year old children~* Ability to swallow tablets~* Uncomplicated malaria caused by P. falciparum~* Asexual parasites ≥ 2000/µl and \< 200000/µl~* Axillary temperature ≥ 37.5°C~* Burkinabe nationality~* Informed consent~Exclusion Criteria:~* Complicated or severe malaria~* Any apparent significant disease~* Anaemia (haematocrit \< 21%)~* Treated in the same trial before~* Antimalarial treatment prior to inclusion (last three days), except children having been treated with chloroquine

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 10 Years
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).